Skye Bioscience, Inc. (SKYE)
NASDAQ: SKYE · Real-Time Price · USD
1.455
-0.135 (-8.49%)
Apr 1, 2025, 10:54 AM EDT - Market open

Skye Bioscience Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Market Capitalization
458634152511
Upgrade
Market Cap Growth
155.60%155.60%126.97%-40.22%130.88%-42.17%
Upgrade
Enterprise Value
-19193317168
Upgrade
Last Close Price
1.592.832.724.0513.0010.00
Upgrade
PB Ratio
0.721.26-15.76-4.924.2223.79
Upgrade
P/TBV Ratio
1.261.26--4.2223.79
Upgrade
Debt / Equity Ratio
0.010.01-2.16-0.660.363.32
Upgrade
Quick Ratio
15.7715.770.140.122.303.14
Upgrade
Current Ratio
16.3216.320.840.742.463.39
Upgrade
Return on Equity (ROE)
-80.48%-80.48%--1364.20%-269.91%-1313.66%
Upgrade
Return on Assets (ROA)
-44.56%-44.56%-80.28%-120.69%-78.31%-168.39%
Upgrade
Return on Capital (ROIC)
-53.09%-53.09%-1159.18%-328.19%-98.60%-272.61%
Upgrade
Earnings Yield
-53.94%-30.94%-112.07%-131.64%-34.42%-61.18%
Upgrade
FCF Yield
-54.50%-31.26%-41.57%-86.75%-26.52%-56.53%
Upgrade
Buyback Yield / Dilution
-420.79%-420.79%-215.43%-36.56%-75.70%-36.48%
Upgrade
Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q